Market Cap 7.90M
Revenue (ttm) 0.00
Net Income (ttm) -23.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.11
Volume 982,600
Avg Vol 8,289,981
Day's Range N/A - N/A
Shares Out 33.74M
Stochastic %K 25%
Beta 1.09
Analysts Strong Sell
Price Target $2.50

Company Profile

Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. Its lead product candidate, VCN-01 (zabilugene almadenorepvec), a clinical stage oncolytic human adenovirus that is in Phase 1 clinical trials and Phase 2 VIRAGE trial for patients with pancreatic cancer, head and neck squamous cell carcinoma, ovarian cancer, colorectal cancer, and retinoblastoma. The company also develops VCN-11 for trea...

Industry: Biotechnology
Sector: Healthcare
Phone: 301 417 4364
Address:
9605 Medical Center Drive, Suite 270, Rockville, United States
Capone78
Capone78 Jul. 13 at 10:03 PM
$TOVX some facts for the believers Company renamed serveral times Sheffield Pharmaceuticals → 2006 Pipex Pharmaceuticals → 2008 Adeona Pharmaceuticals → 2012 Synthetic Biologics → 2022 Theriva Biologics History of 5 Reverse Splits mostly short before rebranding. 03.10.2005 – 1:250 25.04.2007 – 1:3 13.08.2018 – 1:35 25.07.2022 – 1:10 26.08.2024 – 1:25 This is lottery here.
1 · Reply
CeaseNDesist
CeaseNDesist Jul. 13 at 3:52 PM
$TOVX RUN AWAY FROM THIS POS COMPANY
0 · Reply
Saturn909
Saturn909 Jul. 13 at 2:03 AM
$TOVX I’m with Newsweed and voting no!
0 · Reply
StockBoySam
StockBoySam Jul. 13 at 12:35 AM
$TOVX I am voting NO on all accords ...4 nominees · 6 ballot items. My position has not changed.
0 · Reply
Deng42
Deng42 Jul. 12 at 10:31 PM
1 · Reply
dogood
dogood Jul. 10 at 7:34 PM
$TOVX I want three things to ru after hours $TOVX .70 $BURU .45 $LIMN .40 to .75
1 · Reply
dogood
dogood Jul. 10 at 6:57 PM
$TOVX let’s take this to $1 with solid news waiting
0 · Reply
dogood
dogood Jul. 10 at 6:19 PM
$TOVX I really want this to see $1 with great news running to $3
0 · Reply
NickHawkins
NickHawkins Jul. 9 at 4:06 PM
$TOVX curse these phocking pigs brokers, market makers, hedge funds, strip them of their wealth phocking disgusting human scum always out to screw us from cures, from treatments, from potentially life altering medicines to squeeze the few pennies from these capital deprived businesses. Hope they all get sick, get some much needed version of the hell they deserve.
0 · Reply
dogood
dogood Jul. 9 at 1:05 PM
$TOVX look at $VRAX bio stock. Went to $10 this tovx could not even cross .50
0 · Reply
Latest News on TOVX
Theriva Biologics Proxy statement: Proxy filing

Jun 29, 2026, 8:00 AM EDT - 15 days ago

Theriva Biologics Proxy statement: Proxy filing


Theriva Biologics Proxy statement: Proxy filing

Jun 18, 2026, 8:00 AM EDT - 26 days ago

Theriva Biologics Proxy statement: Proxy filing


Theriva Biologics Slides: Corporate presentation

May 13, 2026, 7:00 AM EDT - 2 months ago

Theriva Biologics Slides: Corporate presentation


Theriva Biologics Earnings release: Q1 2026

May 5, 2026, 4:00 PM EDT - 2 months ago

Theriva Biologics Earnings release: Q1 2026


Theriva Biologics Quarterly report: Q1 2026

May 5, 2026, 4:00 PM EDT - 2 months ago

Theriva Biologics Quarterly report: Q1 2026


Theriva Biologics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Theriva Biologics Proxy statement: Proxy filing


Theriva Biologics Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 3 months ago

Theriva Biologics Proxy statement: Proxy filing


Theriva Biologics upgraded to Buy from Hold at Maxim

2026-03-31T11:54:39.000Z - 3 months ago

Theriva Biologics upgraded to Buy from Hold at Maxim


Theriva Biologics Proxy statement: Proxy Filing

Mar 16, 2026, 8:00 AM EDT - 4 months ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics sees cash runway into 1Q27

2026-03-12T12:05:50.000Z - 4 months ago

Theriva Biologics sees cash runway into 1Q27


Theriva Biologics Earnings release: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 4 months ago

Theriva Biologics Earnings release: Q4 2025


Theriva Biologics Annual report: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 4 months ago

Theriva Biologics Annual report: Q4 2025


Theriva Biologics Proxy statement: Proxy Filing

Mar 4, 2026, 7:00 AM EST - 4 months ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics licenses SYN-020 to Rasayana Therapeutics

2026-02-18T13:16:44.000Z - 5 months ago

Theriva Biologics licenses SYN-020 to Rasayana Therapeutics


Theriva Biologics Proxy statement: Proxy Filing

Jan 5, 2026, 7:00 AM EST - 6 months ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics Proxy statement: Proxy Filing

Dec 23, 2025, 7:00 AM EST - 7 months ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year

2025-11-12T13:16:18.000Z - 8 months ago

Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year


Theriva Biologics Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 8 months ago

Theriva Biologics Quarterly report: Q3 2025


Theriva Biologics Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 8 months ago

Theriva Biologics Earnings release: Q3 2025


Theriva Biologics Proxy statement: Proxy Filing

Nov 12, 2025, 7:00 AM EST - 8 months ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics Proxy statement: Proxy Filing

Nov 10, 2025, 7:00 AM EST - 8 months ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics Registration statement: Registration Filing

Nov 7, 2025, 7:00 AM EST - 8 months ago

Theriva Biologics Registration statement: Registration Filing


Theriva Biologics Proxy statement: Proxy Filing

Oct 31, 2025, 8:00 AM EDT - 9 months ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics Provides Response to Unusual Market Action

Oct 24, 2025, 2:31 PM EDT - 9 months ago

Theriva Biologics Provides Response to Unusual Market Action


Theriva Biologics sees cash runway into 1Q26

2025-08-11T12:12:22.000Z - 1 year ago

Theriva Biologics sees cash runway into 1Q26


Theriva Biologics Quarterly report: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 1 year ago

Theriva Biologics Quarterly report: Q2 2025


Theriva Biologics Earnings release: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 1 year ago

Theriva Biologics Earnings release: Q2 2025


Theriva Biologics Proxy statement: Proxy Filing

Jul 9, 2025, 8:00 AM EDT - 1 year ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics sees cash runway into 1Q26

2025-05-14T12:52:08.000Z - 1 year ago

Theriva Biologics sees cash runway into 1Q26


Theriva Biologics Quarterly report: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Theriva Biologics Quarterly report: Q1 2025


Theriva Biologics Earnings release: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Theriva Biologics Earnings release: Q1 2025


Theriva Biologics Registration statement: Registration Filing

Mar 21, 2025, 8:00 AM EDT - 1 year ago

Theriva Biologics Registration statement: Registration Filing


Theriva Biologics Earnings release: Q4 2024

Mar 6, 2025, 8:30 AM EST - 1 year ago

Theriva Biologics Earnings release: Q4 2024


Theriva Biologics Annual report: Q4 2024

Mar 6, 2025, 8:30 AM EST - 1 year ago

Theriva Biologics Annual report: Q4 2024


Theriva Biologics Registration statement: Registration Filing

Jan 21, 2025, 7:00 AM EST - 1 year ago

Theriva Biologics Registration statement: Registration Filing


Theriva Biologics Registration statement: Registration Filing

Dec 10, 2024, 7:00 AM EST - 1 year ago

Theriva Biologics Registration statement: Registration Filing


Theriva Biologics Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Theriva Biologics Quarterly report: Q3 2024


Theriva Biologics Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Theriva Biologics Earnings release: Q3 2024


Theriva Biologics Proxy statement: Proxy Filing

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics Registration statement: Registration Filing

Sep 23, 2024, 8:00 AM EDT - 1 year ago

Theriva Biologics Registration statement: Registration Filing


Theriva Biologics Proxy statement: Proxy Filing

Sep 18, 2024, 8:00 AM EDT - 1 year ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics Registration statement: Registration Filing

Sep 11, 2024, 8:00 AM EDT - 1 year ago

Theriva Biologics Registration statement: Registration Filing


Theriva Biologics Registration statement: Registration Filing

Sep 10, 2024, 8:00 AM EDT - 2 years ago

Theriva Biologics Registration statement: Registration Filing


Theriva Biologics Announces Reverse Stock Split

Aug 16, 2024, 4:05 PM EDT - 2 years ago

Theriva Biologics Announces Reverse Stock Split


Theriva Biologics Quarterly report: Q2 2024

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Theriva Biologics Quarterly report: Q2 2024


Theriva Biologics Earnings release: Q2 2024

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Theriva Biologics Earnings release: Q2 2024


Theriva Biologics Quarterly report: Q1 2024

May 7, 2024, 7:00 AM EDT - 2 years ago

Theriva Biologics Quarterly report: Q1 2024


Theriva Biologics Earnings release: Q1 2024

May 7, 2024, 7:00 AM EDT - 2 years ago

Theriva Biologics Earnings release: Q1 2024


Theriva Biologics Registration statement: Registration Filing

May 2, 2024, 8:00 AM EDT - 2 years ago

Theriva Biologics Registration statement: Registration Filing


Theriva Biologics Earnings Call Transcript: Q4 2023

Mar 25, 2024, 8:30 AM EDT - 2 years ago

Theriva Biologics Earnings Call Transcript: Q4 2023


Theriva Biologics Annual report: Q4 2023

Mar 25, 2024, 8:30 AM EDT - 2 years ago

Theriva Biologics Annual report: Q4 2023


Theriva Biologics Earnings release: Q4 2023

Mar 25, 2024, 8:30 AM EDT - 2 years ago

Theriva Biologics Earnings release: Q4 2023


Theriva Biologics Earnings Call Transcript: Q3 2023

Nov 13, 2023, 8:30 AM EST - 2 years ago

Theriva Biologics Earnings Call Transcript: Q3 2023


Theriva Biologics Quarterly report: Q3 2023

Nov 13, 2023, 8:30 AM EST - 2 years ago

Theriva Biologics Quarterly report: Q3 2023


Theriva Biologics Proxy statement: Proxy Filing

Aug 16, 2023, 8:00 AM EDT - 3 years ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics Proxy statement: Proxy Filing

Aug 14, 2023, 8:00 AM EDT - 3 years ago

Theriva Biologics Proxy statement: Proxy Filing


Theriva Biologics Earnings Call Transcript: Q2 2023

Aug 8, 2023, 8:30 AM EDT - 3 years ago

Theriva Biologics Earnings Call Transcript: Q2 2023


Theriva Biologics Quarterly report: Q2 2023

Aug 8, 2023, 8:30 AM EDT - 3 years ago

Theriva Biologics Quarterly report: Q2 2023


Theriva Biologics Earnings Call Transcript: Q1 2023

May 11, 2023, 8:30 AM EDT - 3 years ago

Theriva Biologics Earnings Call Transcript: Q1 2023


Theriva Biologics Quarterly report: Q1 2023

May 11, 2023, 8:30 AM EDT - 3 years ago

Theriva Biologics Quarterly report: Q1 2023


Capone78
Capone78 Jul. 13 at 10:03 PM
$TOVX some facts for the believers Company renamed serveral times Sheffield Pharmaceuticals → 2006 Pipex Pharmaceuticals → 2008 Adeona Pharmaceuticals → 2012 Synthetic Biologics → 2022 Theriva Biologics History of 5 Reverse Splits mostly short before rebranding. 03.10.2005 – 1:250 25.04.2007 – 1:3 13.08.2018 – 1:35 25.07.2022 – 1:10 26.08.2024 – 1:25 This is lottery here.
1 · Reply
CeaseNDesist
CeaseNDesist Jul. 13 at 3:52 PM
$TOVX RUN AWAY FROM THIS POS COMPANY
0 · Reply
Saturn909
Saturn909 Jul. 13 at 2:03 AM
$TOVX I’m with Newsweed and voting no!
0 · Reply
StockBoySam
StockBoySam Jul. 13 at 12:35 AM
$TOVX I am voting NO on all accords ...4 nominees · 6 ballot items. My position has not changed.
0 · Reply
Deng42
Deng42 Jul. 12 at 10:31 PM
1 · Reply
dogood
dogood Jul. 10 at 7:34 PM
$TOVX I want three things to ru after hours $TOVX .70 $BURU .45 $LIMN .40 to .75
1 · Reply
dogood
dogood Jul. 10 at 6:57 PM
$TOVX let’s take this to $1 with solid news waiting
0 · Reply
dogood
dogood Jul. 10 at 6:19 PM
$TOVX I really want this to see $1 with great news running to $3
0 · Reply
NickHawkins
NickHawkins Jul. 9 at 4:06 PM
$TOVX curse these phocking pigs brokers, market makers, hedge funds, strip them of their wealth phocking disgusting human scum always out to screw us from cures, from treatments, from potentially life altering medicines to squeeze the few pennies from these capital deprived businesses. Hope they all get sick, get some much needed version of the hell they deserve.
0 · Reply
dogood
dogood Jul. 9 at 1:05 PM
$TOVX look at $VRAX bio stock. Went to $10 this tovx could not even cross .50
0 · Reply
andytran339
andytran339 Jul. 8 at 4:43 PM
$TOVX company cant start phase 3 alone, they must get a partner. yesterday good news makes it more likely for a partnership to occur. I thought it would run pass 0.50. Being 10% was a total surprised.
0 · Reply
dogood
dogood Jul. 8 at 1:41 PM
$TOVX waiting for .30 break
0 · Reply
Saturn909
Saturn909 Jul. 8 at 12:46 PM
$TOVX Get approval for phase 3 market brings this down. Market is run by criminals and psychopaths that use synthetic shorting to injure retail investors.
0 · Reply
dogood
dogood Jul. 8 at 12:16 PM
$TOVX The VIRAGE2 trial builds on the results of the 112-patient VIRAGE Phase 2b clinical trial evaluating VCN-01 in treatment naïve metastatic pancreatic ductal adenocarcinoma (PDAC) patients receiving gemcitabine/nab-paclitaxel standard-of-care (SoC) chemotherapy. In the VIRAGE trial, patients who received 2 doses of VCN-01 administered 3 months apart had significantly improved overall survival, progression free survival, and duration of response compared to patients treated with only one dose of VCN-01 or with SoC chemotherapy alone. As previously reported, both the EMA and the FDA recognized the improved survival in the group treated with 2 doses of VCN-01, and raised the possibility of more frequent repeated dosing of VCN-01 in combination with SoC chemotherapy to potentially improve clinical outcomes.
0 · Reply
dogood
dogood Jul. 8 at 12:12 PM
$TOVX should have crossed $1 base on the news.. also there is no dilution , but no reason to be at .222 Theriva Biologics(TOVX) said Tuesday that the Spanish Agency of Medicines and Medical Devices has authorized the company to begin a phase 2a clinical trial evaluating its cancer therapy zabilugene almadenorepvec (VCN-01) to treat metastatic pancreatic The trial will assess a more frequent dosing schedule of VCN-01 in combination with standard-of-care gemcitabine and nab-paclitaxel chemotherapy, it said. Theriva said the study builds on results from its VIRAGE Phase 2b trial, where patients receiving two doses of VCN-01 showed improved overall survival, progression-free survival and duration of response compared with other treatment groups.
0 · Reply
dogood
dogood Jul. 8 at 11:21 AM
$TOVX when can we see .50?
1 · Reply
calibubbles
calibubbles Jul. 8 at 1:55 AM
$TOVX Good chemistry but absolute fucking scumbag grifters at the helm.
0 · Reply
dogood
dogood Jul. 8 at 1:46 AM
$TOVX really good company, should have been $2
0 · Reply
Z_TradeTracker
Z_TradeTracker Jul. 7 at 10:53 PM
$TOVX long 30,000 today average .2529. fwiw Have a sell in GTC at .55cents I'll check it in a few months, hopefully it pops Good luck everybody
0 · Reply
AiorInvestment
AiorInvestment Jul. 7 at 10:38 PM
$IREN $SMCI $TOVX $VZ ​Before chasing the "500% gains" or "low float runner" posts being pushed by anonymous hype accounts on $VEEE (Twin Vee PowerCats), run it through a basic sanity check: ​The Reverse Split Trap: This stock didn't naturally fall to a "low float." They had to execute a massive 1-for-37 reverse stock split just to prevent being completely delisted from the Nasdaq. ​The Balance Sheet: The company is losing money on its operations, posting deeply negative net income and burning cash. They have routinely diluted shareholders by issuing more stock just to keep the lights on. ​High Risk of Dilution: When micro-cap companies with poor cash flow get a sudden, artificial price spike from a social media pump, management almost always uses that opportunity to dump new shares onto the market to raise cash—crashing the price instantly. ​The Verdict: This isn't an "undervalued gem." It is a classic high-risk speculative play ​
0 · Reply
dogood
dogood Jul. 7 at 10:24 PM
$TOVX go green
0 · Reply
gan23
gan23 Jul. 7 at 9:22 PM
$TOVX damn this is dumping so hard. Usually has a good run on good PR. No luck today
0 · Reply